Concordance, variance, and outliers in 4 contemporary cardiac troponin assays: Implications for harmonization

Clinical Chemistry

Volumn 58, Issue 1, 2012, Pages 274-283

  Ungerer, Jacobus P J ^a   Marquart, Louise ^b   O'Rourke, Peter K ^b   Wilgen, Urs ^a   Pretorius, Carel J ^a  

^a Pathology Queensland ^*  (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I; TROPONIN T;

ARTICLE; CONTROLLED STUDY; DIAGNOSIS RELATED GROUP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; PROTEIN DETERMINATION; VARIANCE;

BIOLOGICAL MARKERS; CLINICAL CHEMISTRY TESTS; HUMANS; QUALITY CONTROL; TROPONIN I;

EID: 84856076075     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.175059     Document Type: Article

References (18)

1. Thygsen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-38. (Pubitemid 47616190)
2. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007;53:552-74. (Pubitemid 46580223)
3. Apple FS, Jesse RL, Newby KL, Wu AHB, Christenson RH. National Academy of Clinical Biochemistry and IFCC committee for standardization of markers of cardiac damage laboratory medicine practice guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 2007;53:547-51. (Pubitemid 46580222)
4. Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010;31:2197-206.
5. Panteghini M, Bunk DM, Christenson RH, Katruhka A, Porter RA, Schimmel H, et al. Standardization of troponin I measurement: an update. Clin Chem Lab Med 2008;46:1501-6.
6. Pretorius CJ, Dimeski G, O'Rourke PK, Marquart L, Tyack SA, Wilgen U, Ungerer JPJ. Outliers as a cause of false cardiac troponin results: investigating the robustness of 4 contemporary assays. Clin Chem 2011;57:710-8.
7. Searle RS, Casella G, McCulloch CE. Variance components. Wiley-Interscience 1992:112-67.
8. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-10. (Pubitemid 16134762)
9. Ungerer JPJ, Ungerer MJ, Vermaak WJH. Discordance between measured and calculated total carbon dioxide. Clin Chem 1990;36:2093-6. (Pubitemid 120000543)
10. James S, Flodin M, Johnston N, Lindahl B, Venge P. The antibody configurations of cardiac troponin I assays may determine their clinical performance. Clin Chem 2006;52:832-7.
11. Venge P, James S, Jansson L, Lindahl B. Clinical performance of two highly sensitive cardiac troponin I assays. Clin Chem 2009;55:109-16.
12. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-67.
13. La'ulu SL, Roberts WL. Performance characteristics of five cardiac troponin I assays. Clin Chim Acta 2010;411:1095-101.
14. Tate JR. Troponin revisited 2008: assay performance. Clin Chem Lab Med 2008;46:1489-500.
15. Panteghini M. A critical appraisal of experimental factors influencing the definition of the 99th percentile limit for cardiac troponins. Clin Chem Lab Med 2009;47:1179-82.
16. Apple FS, Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012;58:54-61.
17. Ungerer JPJ, Pretorius CJ, Dimeski G, O'Rourke PK, Tyack SA. Falsely elevated troponin I results due to outliers indicate a lack of analytical robustness. Ann Clin Biochem 2010;47:242-7.
18. Adamczyk M, Brashear RJ, Mattingly PG. Coprevalence of autoantibodies to cardiac troponin I and T in normal blood donors. Clin Chem 2010;56:676-7.